A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis

QR Code

A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis

Introduction: Malignant pleural mesothelioma (MPM) is a rare cancer with a heterogeneous prognosis. Prognostic models are not widely utilized clinically. Classification and regression tree (CART) analysis examines the interaction of multiple variables with a given outcome. Methods: Between 2005 and...

Full description

Bibliographic Details
Main Authors:	Brims, Fraser, Meniawy, T., Duffus, I., De Fonseka, D., Segal, A., Creaney, J., Maskell, N., Lake, R., De Klerk, N., Nowak, A.
Format:	Journal Article
Published:	2016
Online Access:	http://hdl.handle.net/20.500.11937/37994

Similar Items

Prognostic factors for malignant pleural mesothelioma
by: Brims, Fraser, et al.
Published: (2013)

ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)

Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)

Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)

Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)

Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)

Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)

Early specialist palliative care on quality of life for malignant pleural mesothelioma: A randomised controlled trial
by: Brims, Fraser, et al.
Published: (2019)

Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life.
by: Jeffery, E., et al.
Published: (2019)

Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)

RESPECT-MESO: AN INTERNATIONAL MULTICENTRE NON-BLINDED RANDOMIZED CONTROLLED TRIAL TO ASSESS THE IMPACT OF REGULAR EARLY SPECIALIST PALLIATIVE CARE IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2017)

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)

Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)

Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)

Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)

Validation of an Asbestos Job-Exposure Matrix: Exposure-Response Relationships for Malignant Mesothelioma
by: Kamiya, H., et al.
Published: (2018)

Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)

The continual search for ideal biomarkers for mesothelioma: The hurdles
by: Brims, Fraser, et al.
Published: (2013)

Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)

Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
by: Olsen, N., et al.
Published: (2011)

Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)

Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)

Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)

SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)

Asbestos Related Pleural Diseases
by: Brims, Fraser, et al.
Published: (2016)

A randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma - 'RESPECT-Meso'
by: Brims, Fraser, et al.
Published: (2018)

PLEURAL PLAQUES DO NOT INCREASE LUNG CANCER RISK IN ASBESTOS-EXPOSED
by: Kong, K., et al.
Published: (2018)

A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)

Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: A multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters
by: Azzopardi, M., et al.
Published: (2016)

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)

Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom
by: Reid, Alison, et al.
Published: (2018)

Presence of pleural plaques and/or asbestosis and the risk of lung cancer in a crocidolite asbestos exposed population from Western Australia
by: Brims, Fraser, et al.
Published: (2016)

Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up
by: Berry, G., et al.
Published: (2012)

PREDICTION MODELING USING ROUTINE CLINICAL PARAMETERS TO STRATIFY SURVIVAL IN MESOTHELIOMA PATIENTS UNDERGOING SURGERY
by: Harris, E., et al.
Published: (2017)

Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells
by: Fox, Simon, et al.
Published: (2013)

A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): Study protocol for a randomised controlled trial
by: Gunatilake, S., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0eduru6of32oadbbc90nt9mp7b